ArticleLiver cancer2026

Efficacy of Nivolumab plus Ipilimumab in Advanced Hepatocellular Carcinoma with and without High-Risk Features: An International Multicenter Study.

Jung Sun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.